Closed · CDC-RFA-PS21-21030301SUPP23 · CFDA 93.270 · Discretionary
Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement
Federal grant opportunity posted by Centers for Disease Control - NCHHSTP, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- March 27, 2023
- Close date
- 10
- Expected awards
The verdict
Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement is a closed discretionary listing from Centers for Disease Control - NCHHSTP that offered Varies by applicant across 10 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 10
- expected awards
- 93.270
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments Supplement - is cataloged under number CDC-RFA-PS21-21030301SUPP23 and tied to CFDA assistance listing 93.270, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on February 3, 2023 and last updated on February 7, 2023. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. The agency has projected $250,000 in total estimated funding for this announcement. It expects to issue 10 awards. If the agency funds the expected 10 awards from the $250,000 estimated pool, the average award works out to roughly $25,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on March 27, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
March 27, 2023
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
February 3, 2023
Est. Total Funding
$250,000
Expected Awards
10
Instrument
Cooperative Agreement
Description
The purpose of this NOFO is to announce the availability of supplemental funding for the organizations that were previously awarded funding under Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments (CDC-RFA-PS21-2103) (IVHSP). The primary goals of this Supplemental NOFO are to: 1) increase the early detection and interruption of hepatitis C outbreaks and transmission clusters; and 2) increase hepatitis B and hepatitis C diagnosis and treatment by providing routine testing and linkage to prevention and treatment in high-impact settings. This Supplemental NOFO includes two components and applicants may apply for one or both of the following components: Component 1: Integrating Genomic and Epidemiologic Surveillance for Outbreak Detection and Response. The purpose of this project is to work with health departments to develop an integrated epidemiological and molecular surveillance system for HCV infection to identify HCV transmission clusters and outbreaks for public health action. Component 2: Increasing Access to Hepatitis C and/or Hepatitis B Testing and Linkage to Care in High-Impact Settings. The purpose of this project is to work with partners to conduct testing and linkage to care for hepatitis B virus (HBV) and/or HCV infection in high-impact settings (e.g., syringe services programs or SSPs, substance use disorder treatment centers, correctional facilities, emergency departments, and sexually transmitted infections clinics).
Eligibility
Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Clarisse Tsang DVH_FOA@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |